Scarborough Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Scarborough Advisors's LLY Position: Q2 2026 in Review
Scarborough Advisors reduced its Eli Lilly (LLY) stake by 1.4% in Q2 2026, selling an estimated $10.2K and leaving 723 shares worth $820K. The position accounts for 0.09% of the portfolio, ranked #76.
Scarborough Advisors first reported a position in LLY in Q3 2023 and has held it in 6 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Scarborough Advisors held 723 shares of Eli Lilly worth $820K as of Q2 2026.
- Scarborough Advisors sold 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
- Eli Lilly made up 0.09% of Scarborough Advisors's portfolio in Q2 2026, its #76 holding.
- Scarborough Advisors first reported a position in Eli Lilly in Q3 2023 and has held it in 6 quarters since.
- 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Scarborough Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.